Notice of Public Meeting and Availability for Public Comment, 56764-56765 [E7-19613]
Download as PDF
<![CDATA[
56764
Federal Register / Vol. 72, No. 192 / Thursday, October 4, 2007 / Notices
and order materials and resources by
phone using the NPIN toll-free reference
and referral line or electronic mail
system. As of January 25, 2007, over
370,000 unique requests for materials
have been logged and 4,561,186
materials have been ordered by the
public.
The primary purposes of the proposed
data collection are to assess CDC NPIN
users’ satisfaction and perceived quality
with the Web site, products, and
services; determine the extent to which
the users’ needs are being met; and
identify how the Web site, products,
and services can be enhanced to meet
the needs of the user.
The evaluation will be accomplished
by survey data collection from users of
the CDC NPIN Web site and users of
CDC NPIN products and services.
Organizations that do not have access to
the Internet will be administered the
survey by phone.
The estimated 5,655 respondents
include representatives from
government agencies, community-based
organizations, advocacy organizations,
and various other organizations
involved in the prevention and/or
treatment of HIV/AIDS, STDs, TB, and/
or viral Hepatitis.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are
2,525.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Type of respondent
NPIN Website User Survey ............................
NPIN Products and Services User Survey .....
All NPIN Users (Individuals) ..........................
Private Sector Organizations .........................
State and local government organization ......
Federal government organization ..................
Individual/Households ....................................
Private Sector Organizations .........................
State and local government organization ......
Federal government organization ..................
Individual/Households ....................................
NPIN Products and Services User Survey
(Telephone).
Dated: September 27, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–19620 Filed 10–3–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–110]
Notice of Public Meeting and
Availability for Public Comment
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of Public Meeting and
Availability for Public Comment.
pwalker on PROD1PC71 with NOTICES
AGENCY:
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces a public meeting and request
for public input regarding a proposed
survey of U.S. truck driver safety and
health. The goal of the survey is to
collect information on truck driver
health, sleep disorders, fatigue, working
conditions, and non-fatal injuries.
Further information on the proposed
VerDate Aug<31>2005
16:20 Oct 03, 2007
Jkt 214001
survey may be found at: https://
www.cdc.gov/niosh/review/public/110.
Public Comment Period: From date of
publication of this notice until January
2, 2008.
Public Meeting Date and Time:
Thursday, November 1, 2007, 8:30 a.m.–
4:30 p.m., CST.
Place: Westin O’Hare Hotel, 6100
North River Road, Rosemont, Illinois
60018, telephone (888) 627–8517.
Purpose of the Meeting: To obtain
public comment on the content and
conduct of a nationally representative
survey of truck drivers’ safety and
health. Special emphasis will be placed
on discussion of the following:
(1) Content of the survey.
(2) Appropriate methods of
conducting such a survey.
Status: The forum will include
scientists and representatives from
various government agencies, industry,
labor, and other stakeholders, and is
open to the public. Attendance is
limited only by the space available. The
meeting room will accommodate
approximately 70 people. Interested
parties should make hotel reservations
directly with the Westin O’Hare Hotel
by calling (888) 627–8517 or via the
Web site at https://
www.starwoodmeeting.com/Book/
westatOc before the cut-off date of 5
p.m. CST October 10, 2007. A special
group rate of $205.00 per night (or
prevailing government rate) plus tax per
night for meeting guests has been
negotiated for this meeting. In order to
receive the special room rate, you will
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
1,078
2,155
222
94
1,648
239
25
11
183
Number of responses per
respondent
1
2
2
2
2
2
2
2
2
Average
burden per
response
13/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
15/60
need to indicate that you will be
attending the NIOSH meeting.
Interested parties should confirm
their attendance to this meeting by
contacting Ms. Mary K. Dingwall,
meeting coordinator, at (301) 738–3583
or MaryDingwall@Westat.com by
October 19, 2007. Oral comments given
at the meeting will be recorded and
included in the docket. Written
comments will also be accepted at the
meeting or by submitting them to the
NIOSH Docket Office.
Contact Person for Technical
Information: Karl Sieber, NIOSH/CDC,
Robert A. Taft Laboratories, 4676
Columbia Pkwy. MS R–17, Cincinnati,
OH 45226, telephone (513) 841–4231, or
Stephanie Pratt, NIOSH/CDC, 1095
Willowdale Road, MS 1808,
Morgantown, WV 26505, telephone
(304) 285–5992.
Contact Person for Submitting
Comments: Comments on the topics
presented in this notice and at the
meeting should be mailed to: NIOSH
Docket Office, Robert A. Taft
Laboratories, MS–C34, 4676 Columbia
Parkway, Cincinnati, Ohio 45226,
telephone (513) 533–8450, fax (513)
533–8285. Comments may also be
submitted by e-mail to
nioshdocket@cdc.gov or at https://
www.cdc.gov/niosh/review/public/110/.
E-mail attachments should be formatted
in Microsoft Word. All comments
should be received by January 2, 2008
and should reference the Docket
Number (NIOSH–110) in the subject
heading.
E:\FR\FM\04OCN1.SGM
04OCN1
Federal Register / Vol. 72, No. 192 / Thursday, October 4, 2007 / Notices
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226 and at https://
www.cdc.gov/niosh/docket/
default.html.
Dated: September 26, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E7–19613 Filed 10–3–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Proposed Consolidated Vaccine
Information Materials for Multiple
Infant Vaccines
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
pwalker on PROD1PC71 with NOTICES
AGENCY:
SUMMARY: Under the National
Childhood Vaccine Injury Act (NCVIA)
(42 U.S.C. 300aa–26), the CDC must
develop vaccine information materials
that all health care providers are
required to give to patients/parents prior
to administration of specific vaccines.
CDC seeks written comment on a
proposed new vaccine information
statement that consolidates the six
vaccine information statements for the
following childhood vaccines: DTaP,
Haemophilus influenzae type b,
inactivated polio vaccine,
pneumococcal conjugate vaccine,
hepatitis B, and rotavirus. This
consolidated Vaccine Information
Statement would be available to be used
by vaccination providers as an
alternative to providing the six
individual Vaccine Information
Statements for the same vaccines.
DATES: Written comments are invited
and must be received on or before
December 3, 2007.
ADDRESSES: Written comments should
be addressed to Anne Schuchat, M.D.,
Director, National Center for
Immunization and Respiratory Diseases,
Centers for Disease Control and
Prevention, Mailstop E–05, 1600 Clifton
Road, N.E., Atlanta, Georgia 30333.
FOR FURTHER INFORMATION CONTACT:
Anne Schuchat, M.D., Director, National
Center for Immunization and
Respiratory Diseases, Mailstop E–05,
1600 Clifton Road, NE., Atlanta, Georgia
30333, telephone (404) 639–8200.
VerDate Aug<31>2005
16:20 Oct 03, 2007
Jkt 214001
The
National Childhood Vaccine Injury Act
of 1986 (Pub. L. 99–660), as amended by
section 708 of Public Law 103–183,
added section 2126 to the Public Health
Service Act. Section 2126, codified at 42
U.S.C. 300aa–26, requires the Secretary
of Health and Human Services to
develop and disseminate vaccine
information materials for distribution by
all health care providers in the United
States to any patient (or to the parent or
legal representative in the case of a
child) receiving vaccines covered under
the National Vaccine Injury
Compensation Program.
Development and revision of the
vaccine information materials, also
known as Vaccine Information
Statements (VIS), have been delegated
by the Secretary to the Centers for
Disease Control and Prevention (CDC).
Section 2126 requires that the materials
be developed, or revised, after notice to
the public, with a 60-day comment
period, and in consultation with the
Advisory Commission on Childhood
Vaccines, appropriate health care
provider and parent organizations, and
the Food and Drug Administration. The
law also requires that the information
contained in the materials be based on
available data and information, be
presented in understandable terms, and
include:
(1) A concise description of the
benefits of the vaccine,
(2) A concise description of the risks
associated with the vaccine,
(3) A statement of the availability of
the National Vaccine Injury
Compensation Program, and
(4) Such other relevant information as
may be determined by the Secretary.
The vaccines initially covered under
the National Vaccine Injury
Compensation Program were diphtheria,
tetanus, pertussis, measles, mumps,
rubella and poliomyelitis vaccines.
Since April 15, 1992, any health care
provider in the United States who
intends to administer one of these
covered vaccines is required to provide
copies of the relevant vaccine
information materials prior to
administration of any of these vaccines.
Hepatitis B, Haemophilus influenzae
type b (Hib), varicella (chickenpox),
pneumococcal conjugate, hepatitis A,
meningococcal conjugate and
polysaccharide, rotavirus, human
papillomavirus (HPV), and trivalent
influenza vaccines have subsequently
been added to the National Vaccine
Injury Compensation Program. Use of
the Vaccine Information Statements
applicable to all of these vaccines,
except meningococcal, rotavirus and
HPV, is also required. (Interim versions
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
56765
of Vaccine Information Statements for
meningococcal, rotavirus and HPV
vaccines are available for discretionary
use pending completion of the statutory
process for finalizing VISs applicable to
those vaccines.) Instructions for use of
the vaccine information materials and
copies of the materials can be found on
the CDC Web site at: https://
www.cdc.gov/vaccines/pubs/vis. In
addition, single camera-ready copies are
available from State health departments.
A list of State health department
contacts for obtaining copies of these
materials is included in a December 17,
1999 Federal Register notice (64 FR
70914).
Proposed Consolidated Vaccine
Information Materials
With six vaccines recommended for
infants from birth through 6 months of
age—all covered by the National
Vaccine Injury Compensation
Program—CDC, as required under 42
U.S.C. 300aa–26, developed Vaccine
Information Statements for each of those
vaccines. CDC is proposing an
alternative consolidated Vaccine
Information Statement covering those
six vaccines in one document, which
providers could choose to use instead of
the existing individual Vaccine
Information Statements for the same
vaccines.
Development of Vaccine Information
Materials
The vaccine information materials
referenced in this notice are being
developed in consultation with the
Advisory Commission on Childhood
Vaccines, the Food and Drug
Administration, and parent and health
care provider groups.
In addition, we invite written
comment on the proposed vaccine
information materials that follow,
entitled ‘‘Your Baby’s First Vaccines:
What You Need to Know.’’ Comments
submitted will be considered in
finalizing these materials. When the
final consolidated VIS is published in
the Federal Register, the instructions for
use of vaccine information materials
will be revised to note that this
alternative consolidated VIS can be used
in lieu of the individual vaccine VISs.
*
*
*
*
*
Proposed Multi-vaccine Vaccine
Information Statement
YOUR BABY’S FIRST VACCINES:
WHAT YOU NEED TO KNOW
Babies are scheduled for six vaccines
at 2, 4, and 6 months of age. One of
these (hepatitis B) is usually given at
birth.
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 72, Number 192 (Thursday, October 4, 2007)]
[Notices]
[Pages 56764-56765]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-19613]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-110]
Notice of Public Meeting and Availability for Public Comment
AGENCY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (HHS).
ACTION: Notice of Public Meeting and Availability for Public Comment.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces a public meeting and request for public input regarding a
proposed survey of U.S. truck driver safety and health. The goal of the
survey is to collect information on truck driver health, sleep
disorders, fatigue, working conditions, and non-fatal injuries. Further
information on the proposed survey may be found at: https://www.cdc.gov/
niosh/review/public/110.
Public Comment Period: From date of publication of this notice
until January 2, 2008.
Public Meeting Date and Time: Thursday, November 1, 2007, 8:30
a.m.-4:30 p.m., CST.
Place: Westin O'Hare Hotel, 6100 North River Road, Rosemont,
Illinois 60018, telephone (888) 627-8517.
Purpose of the Meeting: To obtain public comment on the content and
conduct of a nationally representative survey of truck drivers' safety
and health. Special emphasis will be placed on discussion of the
following:
(1) Content of the survey.
(2) Appropriate methods of conducting such a survey.
Status: The forum will include scientists and representatives from
various government agencies, industry, labor, and other stakeholders,
and is open to the public. Attendance is limited only by the space
available. The meeting room will accommodate approximately 70 people.
Interested parties should make hotel reservations directly with the
Westin O'Hare Hotel by calling (888) 627-8517 or via the Web site at
https://www.starwoodmeeting.com/Book/westatOc before the cut-off date of
5 p.m. CST October 10, 2007. A special group rate of $205.00 per night
(or prevailing government rate) plus tax per night for meeting guests
has been negotiated for this meeting. In order to receive the special
room rate, you will need to indicate that you will be attending the
NIOSH meeting.
Interested parties should confirm their attendance to this meeting
by contacting Ms. Mary K. Dingwall, meeting coordinator, at (301) 738-
3583 or MaryDingwall@Westat.com by October 19, 2007. Oral comments
given at the meeting will be recorded and included in the docket.
Written comments will also be accepted at the meeting or by submitting
them to the NIOSH Docket Office.
Contact Person for Technical Information: Karl Sieber, NIOSH/CDC,
Robert A. Taft Laboratories, 4676 Columbia Pkwy. MS R-17, Cincinnati,
OH 45226, telephone (513) 841-4231, or Stephanie Pratt, NIOSH/CDC, 1095
Willowdale Road, MS 1808, Morgantown, WV 26505, telephone (304) 285-
5992.
Contact Person for Submitting Comments: Comments on the topics
presented in this notice and at the meeting should be mailed to: NIOSH
Docket Office, Robert A. Taft Laboratories, MS-C34, 4676 Columbia
Parkway, Cincinnati, Ohio 45226, telephone (513) 533-8450, fax (513)
533-8285. Comments may also be submitted by e-mail to
nioshdocket@cdc.gov or at https://www.cdc.gov/niosh/review/public/110/.
E-mail attachments should be formatted in Microsoft Word. All comments
should be received by January 2, 2008 and should reference the Docket
Number (NIOSH-110) in the subject heading.
[[Page 56765]]
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226 and at https://
www.cdc.gov/niosh/docket/default.html.
Dated: September 26, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E7-19613 Filed 10-3-07; 8:45 am]
BILLING CODE 4163-18-P
